Adrenal Tumors - Pathogenesis and Therapy

The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Adrenal Tumors Adenocarcinoma Adrenal Cortex Diseases Adrenal Cortex Neoplasms Adrenal Gland Diseases Adrenal Gland Neoplasms Adrenocortical Carcinoma Adrenocortical Hyperfunction Carcinoma Conn Syndrome Cushing Syndrome Endocrine Gland Neoplasms Endocrine System Diseases Hyperaldosteronism Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Neuroectodermal Tumors Neuroendocrine Tumors Paraganglioma Pheochromocytoma

Age range

Up to 100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Wuerzburg

Würzburg, 97080, Germany

Location status: Recruiting

Location contact

Martin Fassnacht, MD

CONTACT

[email protected]

Martin Fassnacht, MD

PRINCIPAL_INVESTIGATOR

Stefanie Hahner, MD

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

adrenal tumor detected by imaging

Exclusion criteria

Study contacts

Contact information is provided by the study sponsor or research team.

Martin Fassnacht, MD

CONTACT

[email protected]

49-931-201-36507

Sponsors and collaborators

Lead sponsor

University of Wuerzburg

Other

Collaborators

Deutsche Krebshilfe e.V., Bonn (Germany)
German Federal Ministry of Education and Research

Registry information

Official study title

Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen

Important dates

Study start: 2002
Primary completion: 2030
Study completion: 2032
First posted: Apr 30, 2008
Registry last updated: May 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting